moderna - Search News

Moderna awarded tender for COVID-19 vaccine

Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High

Shares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned increasingly positive following the company’s announcement of a new vaccine tender agreement.

Benzinga.com · 5h

Moderna Secures European Contract For Covid-19 Vaccine

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to enhance healthcare delivery.

Raleigh News & Observer · 11h

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats

Business Insider · 9h

Moderna awarded tender for COVID-19 vaccine in EU, Norway and North Macedonia

Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North

MarketWatch · 9h

Moderna Receives EU Tender Order for Covid-19 Vaccine

Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was among the world's best-selling medicines in the depths of the pandemic in 2021.

1don MSN

As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Sick of the stomach bug? Moderna is making a norovirus vaccine

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

Where Will Moderna Be in 3 Years?

Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...

Becker's Hospital Review6h

Moderna races to create norovirus vaccines

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

2don MSN

Moderna spikes as Oracle’s Larry Ellison touts AI-driven mRNA vaccines

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Moderna Shares Are Up Today: What's Going On?

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

5don MSN

Is Moderna Stock a Buy?

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Why I Don’t Believe Larry Ellison’s Moderna Stock Hype

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Moderna awarded tender for COVID-19 vaccine

Related topics